0 Évaluations
ID

23842

Description

Study part: Exploratory Biomarker Research Week 38 / Early Withdrawal visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Mots-clés

Versions (1)
  1. 15/07/2017 15/07/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

15 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Exploratory Biomarker Research Week 38 Mepolizumab HES NCT00086658

    Anglais

    Exploratory Biomarker Research Week 38

    1 Formulaires  
    EXPLORATORY BIOMARKER RESEARCH
    Description

    EXPLORATORY BIOMARKER RESEARCH

    Alias
    UMLS CUI-1
    C0005516 (Biological Markers)
    Has the subject provided written consent for exploratory biomarker research?
    Description

    informed consent biomarker

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0021430 (Informed Consent)
    UMLS CUI [1,2]
    C0005516 (Biological Markers)
    Date of Assessment
    Description

    Date of Assessment

    Type de données

    date

    Alias
    UMLS CUI [1]
    C2985720 (Assessment Date)
    Date of Assessment Skin Biopsy
    Description

    Date of Assessment Skin Biopsy

    Type de données

    date

    Alias
    UMLS CUI [1,1]
    C2985720 (Assessment Date)
    UMLS CUI [1,2]
    C0150866 (Biopsy of skin procedure)
    SNOMED
    240977001
    Date of Assessment GI Biopsy
    Description

    Date of Assessment GI Biopsy

    Type de données

    date

    Alias
    UMLS CUI [1,1]
    C2985720 (Assessment Date)
    UMLS CUI [1,2]
    C0005558 (Biopsy)
    SNOMED
    129314006
    LOINC
    LP68311-7
    UMLS CUI [1,3]
    C0017189 (Gastrointestinal tract structure)
    SNOMED
    51289009
    Retour au début de la page

    Similar models

    Exploratory Biomarker Research Week 38

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    EXPLORATORY BIOMARKER RESEARCH
    C0005516 (UMLS CUI-1)
    informed consent biomarker
    Item
    Has the subject provided written consent for exploratory biomarker research?
    boolean
    C0021430 (UMLS CUI [1,1])
    C0005516 (UMLS CUI [1,2])
    Date of Assessment
    Item
    Date of Assessment
    date
    C2985720 (UMLS CUI [1])
    Date of Assessment Skin Biopsy
    Item
    Date of Assessment Skin Biopsy
    date
    C2985720 (UMLS CUI [1,1])
    C0150866 (UMLS CUI [1,2])
    Date of Assessment GI Biopsy
    Item
    Date of Assessment GI Biopsy
    date
    C2985720 (UMLS CUI [1,1])
    C0005558 (UMLS CUI [1,2])
    C0017189 (UMLS CUI [1,3])
    Retour au début de la page 

    Contact

    Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

    Les champs marqués d’un * sont obligatoires.

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial